Table of Contents
Table of Contents
Preface
Chapter 1. Introduction to Flow Cytometry
(Jason H. Kurzer, M.D., Ph.D., and Olga K. Weinberg, M.D., Department of Pathology, Stanford University School of Medicine, Stanford, CA, US)
Chapter 2. Introduction to Flow Cytometric Immunophenotyping of Benign B-Cells
(Teresa A. Scordino, M.D., James P. Harl and Sandra Admire, Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, US)
Chapter 3. Immunophenotyping of Normal and Abnormal Precursor B-cells
(Karen M. Chisholm, M.D., Ph.D., Department of Pathology, Seattle Children’s Hospital, University of Washington, Seattle, WA, US)
Chapter 4. Mature B-Cell Neoplasms
(Daniel F. Boyer, M.D, Ph.D., Department of Pathology, University of Michigan, Ann Arbor, Michigan)
Chapter 5. Flow Cytometry Immunophenotyping of Plasma Cells & Plasma Cell Neoplasms
(Andrew G. Evans, M.D., Ph.D., Department of Pathology and Laboratory Medicine, University of Rochester, Rochester, NY, US)
Chapter 6. Flow Cytometric Immunophenotyping of Benign Reactive T-Cells
(Jean S. Oak, M.D., Ph.D., Department of Pathology, Stanford University School of Medicine, Stanford, CA, US)
Chapter 7. Immunophenotyping of Normal and Neoplastic Immature T-Cells
(Alexa J. Siddon, M.D., and Mina L. Xu, M.D., Department of Pathology & Laboratory Medicine, Yale University School of Medicine, New Haven, CT, US)
Chapter 8. Immunophenotyping of Neoplastic Mature T-Cells
Pawel Mroz, M.D., Ph.D.1*, Gabriela Gheorghe, M.D.2, David M. Dorfman, M.D., Ph.D.3, and
(Michael A. Linden, M.D., Ph.D, Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, US)
Chapter 9. Flow Cytometric Immunophenotyping of NK-Cells
(Aaron R. Victor M.D., Ph.D., and Aharon G. Freud, M.D., Ph.D., Department of Pathology and Laboratory Medicine, Cedars-Sinai, Los Angeles, CA, US, and others)
Chapter 10. Introduction to Flow Cytometric Immunophenotyping of Myeloid Cells
(Xueyan Chen, M.D., Ph.D., and Sindhu Cherian, M.D., Department of Laboratory Medicine, University of Washington, Seattle, WA, US)
Chapter 11. Acute Myeloid Leukemia
(Katelyn Dannheim, M.D., Jason H. Kurzer, M.D., Ph.D., and Olga K. Weinberg, M.D., Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA, US, and others)
Chapter 12. Principles of Minimal Residual Disease Detection: Minimal Residual Disease Assessment in B-Lymphoblastic Leukemia
(Sunita Park, M.D., Department of Pathology, Children’s Healthcare of Atlanta, Atlanta, GA, US, and others)
Chapter 13. Minimal Residual Disease Assessment in Acute Myeloid Leukemia
(Xueyan Chen, M.D., Ph.D., and Sindhu Cherian, M.D., Department of Laboratory Medicine, University of Washington, Seattle, WA, US)
Chapter 14. Minimal Residual Disease Assessment in Plasma Cell Myeloma
(Irina Grigorieva, PhD, Flow Cytometry and Molecular Diagnostics Laboratories, Northside Hospital, Atlanta, GA, US)
Index